MedTrace Logo

MyDiaMate For Remission Of Diabetes Distress In Type 1 Diabetes (MyREMEDY)

NCT06308549 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 660

Last updated 2025-09-22

No results posted yet for this study

Summary

In the MyREMEDY study the investigators research whether the MyDiaMate self-help application is effective in strengthening the mental health of adults with type 1 diabetes in comparison with care as usual. The MyREMEDY study takes place in four countries: The Netherlands, United Kingdom, Spain, and Germany.

Conditions

Interventions

BEHAVIORAL

MyDiaMate

MyDiaMate programme

Sponsors & Collaborators

  • Juvenile Diabetes Research Foundation

    collaborator OTHER

  • King's College London

    collaborator OTHER

  • University of Malaga

    collaborator OTHER

  • Forschungsinstitut der Diabetes Akademie Mergentheim

    collaborator OTHER

  • Maartje de Wit

    lead OTHER

Principal Investigators

  • Maartje de Wit, Dr. · Amsterdam UMC, location VUmc

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-03
Primary Completion
2026-01-31
Completion
2026-01-31

Countries

  • Germany
  • Netherlands
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06308549 on ClinicalTrials.gov